Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market

Diabetes Care Devices Market Size

  • Report ID: GMI3250
  • Published Date: Feb 2024
  • Report Format: PDF

Diabetes Care Devices Market Size

Diabetes Care Devices Market size was valued at around USD 46.1 billion in 2023 and is projected to grow at a CAGR of 10% from 2024 to 2032. Diabetes care devices refer to a range of medical devices designed to help individuals with diabetes manage their condition effectively. These devices play a crucial role in monitoring blood glucose levels, administering insulin, and overall diabetes management.

 

The National Diabetes Statistics Report for 2022 by the CDC (Centers for Disease Control) reveals that the prevalence of diabetes has increased, reaching an estimated 37.3 million cases. This accounts for 11.3% of the U.S. population. Among these cases, 28.7 million people have received a diabetes diagnosis, while approximately 8.6 million individuals have diabetes but remain undiagnosed.
 

The growing prevalence of diabetes across the world is the primary factor propelling the diabetes care devices market expansion. The management and control of diabetes is essential to avoid its complications such as kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. Moreover, rapid urbanization has led to an inactive lifestyle, unhealthy diet, and increased stress levels among youth, that are some major factors that result in diabetes, thereby impacting the overall market demand.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global diabetes care devices industry was valued at around USD 46.1 billion in 2023 and is estimated to reach over USD 107.2 billion by 2032 due to the growing prevalence of diabetes across the world.

The blood glucose monitoring devices segment will record 9.9% CAGR during 2024-2032, attributed to the adoption of CGM systems for continuous and real-time monitoring of glucose levels to ensure optimal care to diabetes patients.

North America diabetes care devices industry accounted for USD 18.6 billion in 2023 and is predicted to witness substantial growth through 2032 due to the ongoing advancements in technology, including the integration of smart features, connectivity, and data-sharing capabilities in medical devices.

Abbott Laboratories, Arkray, Inc., Ascensia Diabetes Care Holding AG, B. Braun Melsungen AG, Becton Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc., Medtronic plc, Nova Biomedical, Inc., Novo Nordisk A/S, Pendiq GmBH, Sanofi, Sinocare, Inc., Tandem Diabetes Care Inc., and Ypsomed AG.

Diabetes Care Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 21
  • Tables & Figures: 606
  • Countries covered: 37
  • Pages: 257
 Download Free Sample